OGD officials offer advice on ANDAs, post-CRL scientific meetings
Regulatory NewsJoanne S. Eglovitch
CDERChemistry, Manufacturing and Controls (CMC)Combination productsGDUFAGenericsProduct developmentQuality Assurance and ControlUnited StatesUS Food and Drug Administration (FDA)